Lifecare ASA: Mandatory notification of trade

Posted: 10/06/2026
Lifecare ASA: Mandatory notification of trade

The Company has been informed that Morten Foros Krohnstad, Chair of the Board and primary insider of Lifecare ASA, has exercised 2,000,000 warrants in Warrants Series 2 for the subscription of 2,000,000 new shares in the Company at a price of NOK 0.24899 per share.

Following this transaction, Morten Foros Krohnstad holds 1,600,000 shares and no warrants in Warrant Series 2 in the Company.

About us
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare’s focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare’s sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Petter Nielsen, CFO, petter.nielsen@lifecare.no, +47 92 24 74 64

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-06-10 16:11 CEST.

Attachments
Lifecare ASA: Mandatory notification of trade
260610 PDMR Attachment Morten Foros Krohnstad

Lifecare ASA: Mandatory notification of trade
260610 PDMR Attachment Morten Foros Krohnstad